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a b s t r a c t
Diagnosis of relapsing–remitting multiple sclerosis requires demonstration disseminated
symptoms in time and space on the basis of neurological assessment or magnetic resonance
imaging ﬁndings. In addition, the diagnosis is conditioned by ruling out other conditions
that may explain the clinical symptoms.
We describe the patient presenting in the initial stage of the disease neurological
symptoms and magnetic resonance imaging lesions, that met criteria for relapsing–remit-
ting multiple sclerosis diagnosis.
The patient was administered immunomodulatory treatment. However, the subsequent
course of the disease tended to verify the diagnosis. Finally, the patient was diagnosed with
intravascular B-cell lymphoma.
Intravascular lymphoma is a rare form of lymphoma characterized by the development
of cancerous cells in the lumen of small and medium-sized blood vessels.
Due to the lack of characteristic biomarkers in laboratory tests and neuroimaging, the
diagnosis is based on histopathological examination of the sample of the affected organ
taken by biopsy. It should be consider in all cases of central nervous system damage of
unknown, undiagnosed etiology.
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Diagnostic criteria for relapsing–remitting multiple sclerosis
(RR–MS) require disseminated symptoms in time and space on
the basis of clinical presentation or magnetic resonance* Corresponding author at: Klinika Neurologii z Pododdziałem Leczenia
Królowej w Rzeszowie, ul. Lwowska 60, 35-301 Rzeszów, Poland. Tel.:
E-mail address: grzek@interia.pl (G. Kloc).
Abbreviations: MRI, magnetic resonance imaging; RIS, radiologically
RR–MS, relapsing–remitting multiple sclerosis; CT, computer tomogra
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0028-3843/# 2016 Polish Neurological Society. Published by Elsevier Simaging (MRI) ﬁndings. In addition, the diagnosis is condi-
tioned by ruling out other causes that may explain the clinical
symptoms.
The sensitivity and speciﬁcity of the current criteria for the
diagnosis of multiple sclerosis (MS) is quite high and amounts
to 60% and 87% respectively. However, there is always a risk of Udaru Mózgu, Kliniczny Szpital Wojewódzki Nr 2 im. Św. Jadwigi
 +48 17 86 64 506.
 isolated syndrome; CSF, cerebrospinal ﬂuid; MS, multiple sclerosis;
phy; IVL, intravascular lymphoma; CNS, central nervous system.
p. z o.o. All rights reserved.
Figs. 1 and 2 – Brain MRI performed at first stage of the
disease. It shows numerous hyperintensive T2-lesions
located periventricular and in the cerebellum.
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mimic MS both in the clinical presentation and MRI [1,2].
We present a case of a female patient presenting
neurological symptoms and MR lesions appropriate for
relapsing–remitting form of MS (RR–MS). The patient was
administered immunomodulatory treatment. However, the
subsequent course of the disease tended to verify the
diagnosis. Finally, the patient was diagnosed with intravascu-
lar B-cell lymphoma.
Only a few cases of intravascular lymphoma imitating
multiple sclerosis were so far described. Generally, they had
more rapid progress from the beginning. No description of a
lymphoma mimicking the relapsing–remitting form of MS was
available in the literature. Therefore, we presented the case
because alive diagnosis is extremely difﬁcult in this disease
and poses a challenge to a neurologist.
2. Case report
A 47-year-old patient complained periodically of headaches
with nausea since May 2014. Neurological examination did
not reveal any abnormalities. Computer tomography (CT) of
the head was performed followed by histopathological
examination of the sample from the left maxillary sinus
and fungal sinusitis was diagnosed. The patient was treated
symptomatically with temporary improvement. Due to
recurring headaches, MRI of the brain was performed which
revealed numerous small hyperintensive T2 lesions, located
periventricular, in the corpus callosum and the cerebellum
and hypointensive T1 lesions, partly with gadolinium
enhancement. The ﬁndings met the MRI criteria for RR–
MS. Due to the lack of other clinical symptoms than
headaches, radiologically isolated syndrome (RIS) was
diagnosed.
In September 2014, the patient experienced subacute
dizziness and slight right-sided hemiparesis. Control MRI
of the head showed an increase in the number of lesions
(Figs. 1 and 2).
A lumbar puncture was performed. Cerebrospinal ﬂuid
(CSF) was clear and colorless, cytosis – 0 cells, protein 56 mg/dl,
glucose 67 mg/dl, chloride 114 mmol/l. There was no presence
of oligoclonal bands, neuroborreliosis was ruled out. The
patient was administered 1 g of methylprednisolone intrave-
nously for 5 consecutive days and neurological symptoms
resolved.
Over the next month, the disease exacerbated again in the
form of double vision, right-sided hemiparesis, balance
disorders and severe headaches. The patient was treated with
steroids with positive outcome. Relapsing–remitting form of
MS was diagnosed at that time and interferon b1b (IFN-b1b)
was administered. The patient was stable and without
neurological deﬁcit during ﬁrst 3 months of IFN-b treatment.
Then relapse occurred – double vision, balance disorders and
right-sided hemiparesis. In addition, the patient showed signs
of depression. Methylprednisolone was administered and
neurological symptoms resolved again. A month later – in
February 2015 generalized seizures occurred. At that time,
since depression and epilepsy were diagnosed, treatment with
interferon was discontinued.The patient was in stable condition until March 2015, when
orientation, speech, balance disorders and right-sided hemi-
paresis gradually escalated. She was admitted to the hospital
and head MRI revealed extensive hyperintensive T2 lesions –
20–34 mm in diameter in both hemispheres of the brain, the
cerebellum, pons and thalamus. Most lesions were with
gadolinium enhancement. Standard methylprednisolone
therapy was administered intravenously, but with no im-
provement. The clinical condition even deteriorated. Disorien-
tation and pyramidal paresis of the lower extremities and the
left upper limb progressed. Damage to the 7th left cranial nerve
and quadriplegic ataxia occurred. The patient fell backward in
Romberg's test and could not walk independently. The results
of additional tests were following Hb 12.4 g/dl, RBC 4.04  106/
ml, PLT 145  103/ml. MRI of the cervical spinal cord was normal,
EEG showed generalized periodic slow delta waves. The
following conditions were considered in the diagnostic
process: the systemic vasculitis, malignancy, acute dissemi-
nated encephalomyelitis (ADEM) and progressive multifocal
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ANCA, dsDNA, anticardiolipin antibodies, anti-b2glicoprotein I
antibodies, complement components, immunoglobulins, pro-
tein electrophoresis, LE cells, serum tumor markers, OB,
abdominal ultrasound, chest X-ray were normal. LDH was
not determined. No pathologies in CNS vessels were found
(MRI angiography). Anti-JC virus antibody was present.
Plasmapheresis treatment was attempted but due to lack of
improvement it was discontinued after the third procedure.
The patient's condition deteriorated rapidly – she was drowsy
with a signiﬁcant paresis of the left upper limb and lower
limbs. MRI of the head was repeated, which showed a
signiﬁcant increase in size of previously reported lesions,
some of that had hemorrhagic character accompanied by
considerable swelling (Figs. 3–5). Methylprednisolone and
acyclovir, antifungal agent, immunoglobulin were adminis-
tered again. No improvement was observed. The patient
required ventilation after 2 weeks of hospitalization and died
on the 18th day of the treatment. Histopathological examina-
tion of brain tissue revealed the presence of cells of lymphoid
origin (LCA+, CD20+) in the lumen of the small and medium
blood vessels, small perimural thrombus in some vessels,
chronic inﬂammatory inﬁltration of CD3+ around blood
vessels. No signiﬁcant lesions were found in other organs.
The cause of death was determined as the proliferative
disease of the lymphatic system located in the CNS –
intravascular B-cell lymphoma (Fig. 6).
3. Discussion
Intravascular lymphoma (IVL) is a rare form of non-Hodgkin's
lymphoma characterized by the development of cancerous
cells in the lumen of small and medium-sized blood vessels
including capillaries. The incidence of this condition is rare –
less than 1 case per million. It affects people aged 34–90 years,
on average in their 60s and 70s, the incidence is equal in men
and women. The most common organ locations include the
central nervous system (41%) and skin (20%), but almost any
organ can be affected – lungs, liver, spleen, kidneys, adrenals,
rarely bone marrow, lymph nodes [3–7].
General symptoms include fever of unknown etiology
(25%), less frequently fatigue, loss of appetite, night sweats [5].
In case of the nervous system, mainly the brain, less
frequently the spinal cord, nerve roots and peripheral nerves
are affected. Clinical presentation includes headaches, sei-
zures, consciousness disorders, cognitive disorders and focal
symptoms depending on the location of focal damage.
Neurological syndrome in patients is determined based on
a complex multifocal CNS damage, recurrent stroke episodes,
subacute progressive encephalopathy, dementia, myelopathy,
polyradiculoneuropathy, including cauda equina syndrome,
cranial neuropathies [4–6].Figs. 3–5 – Brain MRI performed at final stage of the disease.
It shows extensive hyperintesive T2- and FLAIR-lesions
accompanied by considerable swelling in both
hemispheres of the brain, the cerebellum and thalamus.
Fig. 6 – Photomicrograph of the brain (H and E stain)
showing the presence of the lymphoid neoplastic cells in
the lumen of the small blood vessels.
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which and as a nonspeciﬁc symptom were explained by
sinusitis. Also subsequent course did not arouse suspicion of
disease of the lymphatic system. The patient had recurrent
scattered neurological symptoms and the results of laboratory
tests were normal.
Routine laboratory examination usually detects elevated
ESR and CRP, slight anemia (63%), high levels of lactate
dehydrogenase (82%), beta2-microglobulin (86%), soluble Il-2
receptors and Il-6 in patients with intravascular lymphoma.
Thrombocytopenia and leucopenia are less frequent (24%). In
less than 5% of cases lymphoma cells are found in peripheral
blood smear [4,5,7–9].
Increased pleocytosis and elevated protein levels are
usually in cerebrospinal ﬂuid (CSF). Baehring et al. described
a group of seven patients with IVL of the brain, lymphocytosis
was found in CFS of six of them [11]. However, pleocytosis was
not found in case of our patient and protein levels were within
the range observed in patients with RR–MS. These facts were in
favor of maintaining the diagnosis of RR–MS. In addition, no
atypical cells were found in CSF, which is consistent with most
authors' observations, since the presence of lymphoma cells in
smears of CSF is rarely observed even in advanced cases
[4,8,9,11].
MRI of the brain in IVL patients shows multiple scattered
foci hyperintensive in T2-weighted and FLAIR images suggest-
ing lesions of vascular or demyelinating origin located mainly
in the white subcortical and cortical matter. These lesions may
be the subject to contrast enhancement. Major lesions with
surrounding edema can mimic a tumor. Sometimes there is a
focal reinforcement in dura [8,9]. MRI of our patient at the early
stage of disease showed the presence of lesions with
morphology and location typical for MS.
The MR image was found atypical only in the subsequent
tests. Despite the treatment, the number and size lesions
increased, some were the subject of secondary hemorrhagic
transformation accompanied by extensive swelling. There
were also lesions within the basal ganglia.The cerebral angiography may not show any lesions, as in
the present case. However, in approximately 45% of cases, a
multifocal narrowing and widening of vessels or their
obstruction as in vasculitis are observed [12].
Due to the lack of characteristic biomarkers in laboratory
tests and neuroimaging, the diagnosis is based on histopath-
ological examination of the sample of the affected organ
(brain, lung, skin, marrow) taken by biopsy [3,5,9,11]. Skin
biopsy of not only the affected sites but also from several
seemingly unchanged sites is particularly helpful in the
diagnosis. It should be conducted in all cases of CNS damage
of unknown, undiagnosed etiology.
Lymphoma cells are in most cases derived from B-cells
(CD19+, CD 20+, CD 22+, CD79+) (88% of cases), rare (2–8%) of T
cells and NK cells [3–7]. Histopathology test revealed the
presence of LCA+, CD20+ cells in our patient, therefore it was
diagnosed as a B-cell lymphoma.
The basic treatment is chemotherapy, according to R-CHOP
(rituximab, cyclophosphamide, adriamycin, vincristine, pred-
nisolone). High doses of methotrexate, corticosteroids and
plasmapheresis are used in cases of CNS involvement [5,7–10].
Steroids were administered repeatedly and also plasma-
pheresis during a signiﬁcant exacerbation in the reported case.
Initially, the condition of the patient improved, but at a later
period that treatment was no longer effective. Most likely, this
was due to the signiﬁcant progress of the underlying disease.
The presented case shows considerable difﬁculties in the
diagnostic process of patients with multifocal brain damage.
The diagnostic criteria for RR–MS were met in our patient – the
course of exacerbations and remissions, multifocal lesions
changing in time in MRI of the brain. This allowed to establish
the diagnosis of RR–MS and start the treatment with beta-1b
interferon. The fact that the existing neurological symptoms
resolved after treatment with steroids supported the diagno-
sis. Further rapid course of the disease tended to verify the
diagnosis. Intravascular lymphoma was not taken into
account in the differential diagnosis, especially that there
were no typical skin lesions and deviations in the blood
results. Correct determination of MS diagnosis, although it is
based on speciﬁc diagnostic criteria, always requires careful
differential diagnosis and considering other alternative diag-
noses including very rare diseases to explain the clinical
symptoms.
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